Schedule 13G ownership disclosure
TELA BIO INC
Common Stock, $0.001 par value per share · CUSIP: 872381108
Event date: 2025-01-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- North Run Capital, LP
Shares: 1,982,489 · Class: 5%
- North Run Advisors, LLC
Shares: 1,982,489 · Class: 5%
- North Run - Due North Partners, LP
Shares: 1,982,489 · Class: 5%
- North Run GP, LP
Shares: 1,982,489 · Class: 5%
- Todd B. Hammer
Shares: 1,982,489 · Class: 5%
- Thomas B. Ellis
Shares: 1,982,489 · Class: 5%
- Michael Bosco
Shares: 1,982,489 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-079676
- Form type
- SCHEDULE 13G
- Filer
- NORTH RUN CAPITAL, LP
- CIK
- CIK 1212897
- Filed
- May 30, 2025
- Reporting period
- Jan 24, 2025
- Description
- Schedule 13G beneficial ownership